Xinwei Hua
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xinwei Hua has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Andrew T. Chan
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
51 shared publications - Alisa K. Manning
Broad Institute
30 shared publications - Kathleen E. Corey
Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts
30 shared publications - Prasanna K. Challa
Gastroenterology Unit, Massachusetts General Hospital, Boston, MA, USA
30 shared publications - Raymond Taeyong Chung
Liver Center, Gastroenterology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
30 shared publications - Robert M. Wilechansky
Division of Gastroenterology and Hepatology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA
30 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
Physiology-Informed Digital Twin-AI Framework Guides Interpretation of Heterogeneous Pacing Therapy Response in HFpEF
Background: Heart failure with preserved ejection fraction (HFpEF) exhibits marked heterogeneity in response to pacing. Because diastolic relaxation is energy dependent and impaired myocardial energetics are common in HFpEF, we hypothesized that favorable response to accelerated atrial pacing would be defined not only by hemodynamic unloading but also by preserved or improved cardiac efficiency (CE). Methods: Patient-specific digital twins of 146 HFpEF patients were used to train a variational autoencoder that generated a virtual population (n ≈ 25,000), in which simulations quantified pacing-induced changes in left atrial pressure (LAP), systolic blood pressure (SBP), cardiac output (CO), and CE, defining four response phenotypes. Classifiers predicting these phenotypes from baseline clinical variables were trained in the virtual cohort and applied to myPACE, where treatment × predicted-response interactions with trial outcomes were evaluated in exploratory analyses. Results: Across the virtual population, most patients exhibited reduced LAP (95.6%) and increased CO (93.8%), whereas only 36.1% improved CE. In myPACE, the predicted SBP-reduction phenotype showed a significant treatment × predicted-response interaction for NT-proBNP (p = 0.015). In the pacing arm, the predicted SBP-reduction and CE-improving phenotypes were associated with greater quality-of-life improvement, without a significant treatment interaction. Conclusions: A physiology-informed digital twin-AI framework identified a predicted SBP-reduction phenotype associated with differential NT-proBNP response to accelerated pacing in HFpEF. Simulated CE provides a candidate mechanistic explanation for this signal. When routine clinical data are insufficient to identify digital twins, AI trained on twin simulations offers a potentially generalizable route for bringing mechanistic models to such data.
- 17 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
Open AccessPhysiology-Informed Digital Twin-AI Framework Guides Interpretation of Heterogeneous Pacing Therapy Response in HFpEF
Background: Heart failure with preserved ejection fraction (HFpEF) exhibits marked heterogeneity in response to pacing. Because diastolic relaxation is energy dependent and impaired myocardial energetics are common in HFpEF, we hypothesized that favorable response to accelerated atrial pacing would be defined not only by hemodynamic unloading but also by preserved or improved cardiac efficiency (CE). Methods: Patient-specific digital twins of 146 HFpEF patients were used to train a variational autoencoder that generated a virtual population (n ≈ 25,000), in which simulations quantified pacing-induced changes in left atrial pressure (LAP), systolic blood pressure (SBP), cardiac output (CO), and CE, defining four response phenotypes. Classifiers predicting these phenotypes from baseline clinical variables were trained in the virtual cohort and applied to myPACE, where treatment × predicted-response interactions with trial outcomes were evaluated in exploratory analyses. Results: Across the virtual population, most patients exhibited reduced LAP (95.6%) and increased CO (93.8%), whereas only 36.1% improved CE. In myPACE, the predicted SBP-reduction phenotype showed a significant treatment × predicted-response interaction for NT-proBNP (p = 0.015). In the pacing arm, the predicted SBP-reduction and CE-improving phenotypes were associated with greater quality-of-life improvement, without a significant treatment interaction. Conclusions: A physiology-informed digital twin-AI framework identified a predicted SBP-reduction phenotype associated with differential NT-proBNP response to accelerated pacing in HFpEF. Simulated CE provides a candidate mechanistic explanation for this signal. When routine clinical data are insufficient to identify digital twins, AI trained on twin simulations offers a potentially generalizable route for bringing mechanistic models to such data.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S8: Random Forest classifier analysis of plasma metabolite profiles: HCC cases compared to all controls (derivation cohort)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S8: Random Forest classifier analysis of plasma metabolite profiles: HCC cases compared to all controls (derivation cohort)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S7: Metabolite Set Enrichment Analysis in HCC Cases Compared to All Controls
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S7: Metabolite Set Enrichment Analysis in HCC Cases Compared to All Controls
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S4: Random Forest Classifier Analysis for Importance of Individual Plasma Metabolites and Clinical Covariates for Prediction of Hepatocellular Carcinoma in HCC Cases compared to Controls with Cirrhosis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S4: Random Forest Classifier Analysis for Importance of Individual Plasma Metabolites and Clinical Covariates for Prediction of Hepatocellular Carcinoma in HCC Cases compared to Controls with Cirrhosis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S6: Associations of Individual Plasma Metabolites with Risk of Hepatocellular Carcinoma in Multivariable-Adjusted Unconditional Logistic Regression Models in HCC Cases versus All Controls
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S6: Associations of Individual Plasma Metabolites with Risk of Hepatocellular Carcinoma in Multivariable-Adjusted Unconditional Logistic Regression Models in HCC Cases versus All Controls
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Figure S2: Performance of Random Forest-derived pre-diagnostic plasma metabolite signatures and covariate-based signatures in predicting HCC among HCC cases and all controls
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Figure S2: Performance of Random Forest-derived pre-diagnostic plasma metabolite signatures and covariate-based signatures in predicting HCC among HCC cases and all controls
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S2: Subgroup Analyses: Associations of Individual Plasma Metabolites with Risk of Hepatocellular Carcinoma in Multivariable-Adjusted Unconditional Logistic Regression Models in HCC Cases vs. Controls with Cirrhosis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S2: Subgroup Analyses: Associations of Individual Plasma Metabolites with Risk of Hepatocellular Carcinoma in Multivariable-Adjusted Unconditional Logistic Regression Models in HCC Cases vs. Controls with Cirrhosis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S2: Subgroup Analyses: Associations of Individual Plasma Metabolites with Risk of Hepatocellular Carcinoma in Multivariable-Adjusted Unconditional Logistic Regression Models in HCC Cases vs. Controls with Cirrhosis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S2: Subgroup Analyses: Associations of Individual Plasma Metabolites with Risk of Hepatocellular Carcinoma in Multivariable-Adjusted Unconditional Logistic Regression Models in HCC Cases vs. Controls with Cirrhosis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Figure S1: Metabolite set enrichment analysis displaying the top 25 metabolic pathways enriched in HCC cases relative to all controls
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Figure S1: Metabolite set enrichment analysis displaying the top 25 metabolic pathways enriched in HCC cases relative to all controls
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S3: Metabolite Set Enrichment Analysis in HCC Cases Compared to Controls with Cirrhosis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
Supplementary Table S3: Metabolite Set Enrichment Analysis in HCC Cases Compared to Controls with Cirrhosis